Archana Jalota-Badhwar

Title: Archana Jalota-Badhwar: Innovator in Tumor Suppressor Research

Introduction

Archana Jalota-Badhwar is a prominent inventor based in Pune, India. She has made significant contributions to the field of biotechnology, particularly in the area of tumor suppressor research. Her innovative work has led to the development of a unique patent that addresses critical aspects of cancer biology.

Latest Patents

Archana holds a patent titled "Tumor suppressor activating polypeptides and uses thereof." This patent involves chimeric tumor suppressor activating peptides derived from matrix attachment region binding protein (MARBP). The peptides are unique in their sequence, comprising an arginine-rich motif flanked by serine residues. Notably, the first serine residue in a stretch of four consecutive serine residues is phosphorylated by the protein kinase C family of serine-threonine kinases, which is indispensable for its functionality. The phosphorylation is directly correlated to the phosphorylation of p53 at the serine 15 residue, thereby stabilizing it. The peptide activates p53 by modifying it post-translationally, allowing for phosphorylation and translocation of p53 to the nucleus.

Career Highlights

Throughout her career, Archana has worked with esteemed organizations such as the Department of Biotechnology and the National Centre for Cell Science. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community significantly.

Collaborations

Archana has collaborated with notable professionals in her field, including her coworker Samit Chattopadhyay. These collaborations have further enriched her research and innovation efforts.

Conclusion

Archana Jalota-Badhwar is a trailblazer in the field of tumor suppressor research, with a patent that showcases her innovative approach to cancer treatment. Her work continues to inspire and pave the way for future advancements in biotechnology.